Crinetics Pharmaceuticals, Inc. (CRNX)

Crinetics Pharmaceuticals Statistics

Total Valuation

CRNX has a market cap or net worth of $3.01 billion. The enterprise value is $1.71 billion.

Market Cap	3.01B
Enterprise Value	1.71B

Important Dates

The next confirmed earnings date is Thursday, May 8, 2025, after market close.

Earnings Date	May 8, 2025
Ex-Dividend Date	n/a

Share Statistics

CRNX has 93.05 million shares outstanding. The number of shares has increased by 39.11% in one year.

Current Share Class	93.05M
Shares Outstanding	93.05M
Shares Change (YoY)	+39.11%
Shares Change (QoQ)	+14.24%
Owned by Insiders (%)	1.51%
Owned by Institutions (%)	110.64%
Float	91.64M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	2,900.71
Forward PS	600.97
PB Ratio	2.27
P/TBV Ratio	2.27
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	1,647.25
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 23.04, with a Debt / Equity ratio of 0.04.

Current Ratio	23.04
Quick Ratio	22.83
Debt / Equity	0.04
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -32.02% and return on invested capital (ROIC) is -21.53%.

Return on Equity (ROE)	-32.02%
Return on Assets (ROA)	-20.46%
Return on Invested Capital (ROIC)	-21.53%
Return on Capital Employed (ROCE)	-24.65%
Revenue Per Employee	$2,378
Profits Per Employee	-$682,856
Employee Count	437
Asset Turnover	0.00
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -25.16% in the last 52 weeks. The beta is 0.37, so CRNX's price volatility has been lower than the market average.

Beta (5Y)	0.37
52-Week Price Change	-25.16%
50-Day Moving Average	32.83
200-Day Moving Average	46.91
Relative Strength Index (RSI)	53.75
Average Volume (20 Days)	1,173,023

Short Selling Information

The latest short interest is 9.63 million, so 10.35% of the outstanding shares have been sold short.

Short Interest	9.63M
Short Previous Month	8.54M
Short % of Shares Out	10.35%
Short % of Float	10.51%
Short Ratio (days to cover)	8.03

Income Statement

In the last 12 months, CRNX had revenue of $1.04 million and -$298.41 million in losses. Loss per share was -$3.69.

Revenue	1.04M
Gross Profit	-239.12M
Operating Income	-338.85M
Pretax Income	-258.54M
Net Income	-298.41M
EBITDA	-336.07M
EBIT	-338.85M
Loss Per Share	-$3.69

Balance Sheet

The company has $1.35 billion in cash and $51.72 million in debt, giving a net cash position of $1.30 billion or $14.00 per share.

Cash & Cash Equivalents	1.35B
Total Debt	51.72M
Net Cash	1.30B
Net Cash Per Share	$14.00
Equity (Book Value)	1.32B
Book Value Per Share	14.26
Working Capital	1.32B

Cash Flow

In the last 12 months, operating cash flow was -$225.97 million and capital expenditures -$3.84 million, giving a free cash flow of -$229.81 million.

Operating Cash Flow	-225.97M
Capital Expenditures	-3.84M
Free Cash Flow	-229.81M
FCF Per Share	-$2.47

Margins

Gross Margin	n/a
Operating Margin	-32,613.47%
Pretax Margin	-28,720.69%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CRNX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-39.11%
Shareholder Yield	n/a
Earnings Yield	-9.90%
FCF Yield	-7.63%

Analyst Forecast

The average price target for CRNX is $73.36, which is 126.28% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$73.36
Price Target Difference	126.28%
Analyst Consensus	Strong Buy
Analyst Count	12
Revenue Growth Forecast (5Y)	310.49%
EPS Growth Forecast (5Y)	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

CRNX has an Altman Z-Score of 20.75 and a Piotroski F-Score of 2.

Altman Z-Score	20.75
Piotroski F-Score	2